ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ANEB Anebulo Pharmaceuticals Inc

1.43
0.03 (2.14%)
27 Nov 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -2.61M-3.81M-2.86M-2.49M-2.54M-2.76M-1.66M-1.34M
Pre Tax Income -2.61M-3.83M-2.8M-2.5M-2.48M-2.72M-1.65M-1.35M
Net Income -2.61M-3.83M-2.8M-2.5M-2.48M-2.72M-1.65M-1.35M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -2.61M-3.83M-2.81M-2.54M-2.54M-2.76M-1.66M-1.34M
EBITDA -2.61M-3.81M-2.86M-2.49M-2.54M-2.76M-1.66M-1.34M
Year End 30 June 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -174k-3.61M-6.83M-11.78M-8.31M
Pre Tax Income -175k-30.25M-6.83M-11.73M-8.2M
Net Income -175k-38.46M-6.83M-11.73M-8.2M
Preferred Dividends 0-8.21M000
Basic Earnings Per Share (EPS) -0.088-1.515-0.269-0.424-0.293
EBIT -174k-3.62M-6.83M-11.82M-8.3M
EBITDA -174k-3.61M-6.83M-11.78M-8.31M